Active Clearance Technology (ACT) II German Multicenter Trial
NCT02479737 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1113
Last updated 2017-05-02
Summary
Postoperative bleeding is a common consequence after heart surgery which can significantly impact outcomes and costs \[Wynne R, Christensen MC, Dixon B\]. When bleeding occurs, reliable postoperative blood evacuation of the pleural, mediastinal and pericardial spaces with chest tubes is imperative to facilitate pulmonary re-expansion and mediastinal decompression as the patient recovers. When postoperative blood evacuation is inadequate, retained blood complications can result (herein described as the Retained Blood Complications (RBC). RBC is the presence of post-operative pericardial and/or pleural fluid or blood that is diagnosed and may necessitate drainage in the acute or sub-acute setting. The need for treatment and interventions for these conditions represents an impediment to patient recovery and involves both resource and economic consumption for a heart program and the healthcare system at large.
Clinically, Retained Blood Complications (RBC) can be recognized acutely or subacutely. When it presents acutely, it is usually fresh thrombus around the heart or lungs presenting as tamponade or hemothorax. When it presents subacutely, it results in bloody pleural or pericardial effusions. These effusions are often driven by the breakdown of remaining thrombus. Once RBC occurs, subsequent procedures may be needed to remedy it.
A recent review of the literature indicated that additional procedures for RBC are demonstrated in approximately 15% to 20% of patients after heart surgery. In a prospectively collected United States Nationwide Inpatient Sample (NIS) data from 2010, RBC could be demonstrated in 17% of patients. In this analysis, mortality was doubled from 4% to 8%, length of stay was increased by 5 days, and average costs were 55% higher. Patients with RBC, therefore, represent an increased at risk population for complications and costs.
Postoperative obstruction of conventional chest tubes with blood and other fibrinous material in the setting of postoperative bleeding contributes to RBC. (Shalli) In a recent study of postoperative cardiac surgery patients at the Cleveland Clinic, 36% of patients were found to have evidence of chest tube obstruction . Active Clearance with PleuraFlow has been shown to prevent chest tube clogging, and reduce RBC.
Conditions
- Heart Surgery
Interventions
- DEVICE
-
Blood drainage post cardiac surgery using PleuraFlow System
Sponsors & Collaborators
-
ClearFlow, Inc.
collaborator INDUSTRY -
Prof. Dr. Theodor Fischlein
lead OTHER
Principal Investigators
-
Theodor Fischlein, Prof. · Paracelsus Medical University, Klinikum, Nuremberg, Germany
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-04-30
- Primary Completion
- 2017-07-31
- Completion
- 2017-12-31
Countries
- Germany
Study Locations
More Related Trials
-
The ZEro PLASma Trial (ZEPLAST): Avoidance of Fresh Frozen Plasma in Cardiac Surgery
NCT01471730 ·Status: COMPLETED ·Phase: PHASE3
-
Platelet Inhibition and Bleeding in Patients Undergoing Emergent Cardiac Surgery
NCT01468597 ·Status: COMPLETED
-
DEPOSITION - Decreasing Postoperative Blood Loss by Topical vs. Intravenous Tranexamic Acid in Open Cardiac Surgery
NCT03954314 ·Status: TERMINATED ·Phase: PHASE3
-
Comparison of ACT Between Hemochron Jr and ACT Plus
NCT02484157 ·Status: COMPLETED ·Phase: NA
-
Study of Fibrinogen Concentrate (Human) (FCH) to Control Bleeding During Complex Cardiovascular Surgery
NCT01475669 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of the CytoSorb® Filter to Remove Anticoagulants From the Circulation During Emergency Surgery for Aortic Dissection
NCT05235178 ·Status: COMPLETED
-
The DIEP-Flap as a Model of Ischemia-Reperfusion
NCT00482469 ·Status: COMPLETED
-
Prediction of Bleeding and Transfusion Outcomes and Assessment of Perioperative Platelet Reactivity in Cardiac Surgery
NCT02277379 ·Status: COMPLETED
-
Active-control Randomized Trial Comparing 4-factor Prothrombin Complex Concentrate With Frozen Plasma in Cardiac Surgery
NCT05523297 ·Status: COMPLETED ·Phase: PHASE3
-
Fibrinogen Concentrate (FGTW) in Trauma Patients, Presumed to Bleed (FI in TIC)
NCT01475344 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Trial of a Hospital Policy of Tranexamic Acid Use to Reduce Transfusion in Major Non-cardiac Surgery
NCT04803747 ·Status: COMPLETED ·Phase: PHASE4
-
Phase II Study to Compare MDCO-2010 vs Placebo and Tranexamic Acid in Patients Undergoing Cardiac Surgery
NCT01530399 ·Status: TERMINATED ·Phase: PHASE2
-
Desflurane Preconditioning in Hepatectomies
NCT03848780 ·Status: COMPLETED ·Phase: NA
-
Retrospective Chart Analysis in the Effective Use of FloSeal in Post-Operative Joint Replacements
NCT00958945 ·Status: UNKNOWN
-
Pre- Vs Postoperative Thromboprophylaxis for Liver Resection
NCT04731558 ·Status: RECRUITING ·Phase: PHASE4
-
Estimation of Coagulation Factor XIII Activity Based on the Initial Plasma Fibrinogen Level in Trauma
NCT03634215 ·Status: COMPLETED
-
Tranexamic Acid To Reduce Bleeding in Patients Treated With New Oral Anticoagulants Undergoing Dental Extraction
NCT03413891 ·Status: TERMINATED ·Phase: PHASE4
-
Recombinant Activated Factor VII in the Management of Massive Bleeding in Hospital Universiti Sains Malaysia
NCT03251547 ·Status: COMPLETED
-
Anticoagulation and Inflammation Monitoring in Patients After Heart and Vascular Interventions
NCT06222866 ·Status: RECRUITING
-
Transfusion of Cold-stored Platelet Concentrates
NCT02495506 ·Status: COMPLETED ·Phase: NA
-
Extracorporeal Life Support and Modification of Hemostasis
NCT04912336 ·Status: COMPLETED
-
Thrombin Generation in Liver Transplant Surgery
NCT04762550 ·Status: UNKNOWN
-
Multi-national Study Investigating the Effect and Safety of rFXIII on Transfusion Needs in Patients Undergoing Heart Surgery
NCT00914589 ·Status: COMPLETED ·Phase: PHASE2
-
Use of Activated Recombinant FVII in Spinal Surgery
NCT00102037 ·Status: COMPLETED ·Phase: PHASE2
-
Local Tranexamic Acid During Vaginal Hysteractomy to Reduce Blood Loss
NCT04760301 ·Status: RECRUITING ·Phase: NA